GHO Capital appoints Vivid Sehgal as Operating Partner
manilatimes.net · 2026-09-08
Vivid brings over 30 years of operational and financial leadership in healthcare and life sciences, being a founder of LivaNova PLC, led OPEN Health as Interim Group CEO, and held senior roles at GlaxoSmithKline, Allergan, and LGCVivid will draw on his deep industry relationships and operational expertise to support GHO's portfolio companies directly, while also helping to expand the firm's network across the healthcare and life sciences sectorLondon, UK - 8 September 2026: GHO Capital Partners LLP ('GHO”), the European specialist investor in global healthcare, today announced that it has appointed Vivid Sehgal as Operating Partner.
TickrTrends take: GHO Capital's appointment of Vivid Sehgal as Operating Partner represents a strategic move that could influence operational efficiency across its portfolio companies, including LIVN. Given TickrTrends' current assessment that LIVN is fairly valued, investors should monitor whether this leadership addition translates into measurable improvements in operational metrics or cost management that might validate the current valuation range. For a Healthcare sector company trading at fair value, operational enhancements driven by experienced leadership could be a key factor in determining whether the stock offers upside or maintains its current equilibrium.
Read the full story at manilatimes.net →
Is LIVN undervalued? See TickrTrends' fair value analysis →